<?xml version="1.0" encoding="UTF-8"?>
<p>Multivalency as a strategy to enhance binding and inhibition has been widely explored in protein–carbohydrate interactions
 <sup>
  <xref ref-type="bibr" rid="ref17">17</xref>,
  <xref ref-type="bibr" rid="ref18">18</xref>
 </sup> to bridge binding sites
 <sup>
  <xref ref-type="bibr" rid="ref19">19</xref>
 </sup> or inhibit pathogen binding
 <sup>
  <xref ref-type="bibr" rid="ref20">20</xref>
 </sup> by mechanisms such as chelation and statistical rebinding.
 <sup>
  <xref ref-type="bibr" rid="ref21">21</xref>,
  <xref ref-type="bibr" rid="ref22">22</xref>
 </sup> Indeed several examples of multivalent sialic acid containing glycans have been reported. Relatively large molecular entities can take advantage of their size to bridge multiple HA trimers.
 <sup>
  <xref ref-type="bibr" rid="ref23">23</xref>
 </sup> Some of these have yielded potency enhancements of 3–4 orders of magnitude. Such systems include a polyacrylate carrier,
 <sup>
  <xref ref-type="bibr" rid="ref24">24</xref>
 </sup> polyacrylamide,
 <sup>
  <xref ref-type="bibr" rid="ref25">25</xref>,
  <xref ref-type="bibr" rid="ref26">26</xref>
 </sup> polyglutamic acid,
 <sup>
  <xref ref-type="bibr" rid="ref27">27</xref>
 </sup> polyglycerol based nanoparticles,
 <sup>
  <xref ref-type="bibr" rid="ref28">28</xref>,
  <xref ref-type="bibr" rid="ref29">29</xref>
 </sup> chitosan,
 <sup>
  <xref ref-type="bibr" rid="ref30">30</xref>
 </sup> and liposomes.
 <sup>
  <xref ref-type="bibr" rid="ref31">31</xref>
 </sup>
</p>
